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INTRODUCTION
The rate of stepping is conventionally termed 'cadence'. This is typically measured in terms of steps per time interval. This description of stepping rate has been used ambiguously in the literature 1 . It is important that clear definitions of outcomes are reported so that they can be correctly interpreted.
One example where unambiguous characterisation of stepping rate is required is in the assessment of the clinical condition of intermittent claudication (IC). IC is a symptom of leg pain caused by peripheral arterial disease (PAD) associated with narrowing of arteries 2, 3 .
Arterial blockage prevents sufficient blood supply to the leg muscles, making continuous walking challenging 4 . Individuals affected by IC have reported the need to take regular breaks due to ischaemic pain resulting in fragmented walking [5] [6] [7] . Also those with PAD have an exaggerated cardiovascular response to a constant-load walking exercise 8 . To reduce the possibility of claudication pain they reduce their preferred walking speed and step length 7 .
This could reduce the cardiovascular load, allowing extended walking periods before onset of ischaemic pain. Therefore, the quantification of cadence could be used to describe patient's current condition and to characterise progression or recovery following rehabilitation.
Evidence suggests that people with IC take, on average, a smaller number of steps per minute time block (sometimes referred to as an epoch) compared to an unimpaired age matched population 9 , i.e. that people with IC spread out their stepping activity. Gardner et al 9 also reported that participants with IC took fewer steps at specified medium and high number of steps per minute epoch than controls. Gardner et al reported their results as 'cadence', however, their outcomes would more accurately be termed 'step accumulation'.
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Step accumulation is the number of steps taken within a defined time period (e.g. an epoch of one minute), whereas cadence is the rate of stepping during the actual time spent stepping. Dall et al 1 , demonstrated that adults rarely walk continuously for a minute or longer, meaning that steps accumulated per minute time block, as described by Gardner et al 9 , could not be equivalent to true cadence. The lack of clarity in terminology used, could lead to misunderstanding of research findings. The terms 'step accumulation' and 'true cadence' are used here for clarity.
To investigate the importance of using unambiguous terminology to describe stepping rate, this paper examines the true cadence of walking in those with IC compared to unaffected peers. In light of recent evidence of the difference between the concepts of step accumulation and true cadence 1 both of these measurements are presented to allow comparison with literature and to advance understanding of walking behaviour in those with IC. The presentation of both quantities for both those with IC and for those without is used to investigate any differences between outcomes between these groups. It was hypothesised that those with IC would not only take fewer steps overall, but would also walk with lower true cadence than matched controls.
METHODS
Thirty participants with IC were recruited consecutively from an outpatient vascular service 5 . Ankle Brachial Pressure index (ABPi) and duration of IC were recorded. To confirm IC diagnosis for those with high ABPi an exercise test (using a calf ergonometer) was performed in conjunction with Duplex ultrasound and/or Magnetic Resonance Angiogram.
Ethical approval was obtained from NHS Tayside B Research Ethics Committee.
Thirty controls matched for age (±5years) and gender were selected from a database of physical activity records for 'healthy' individuals at Glasgow Caledonian University. Controls had been recruited through contacts of staff at Glasgow Caledonian University, lived in the community and had no medical condition affecting mobility. Ethical approval was gained from Glasgow Caledonian University School of Health and Life Sciences Ethics Committee.
All participants gave informed consent to take part in the study. Gender, age, height and weight were recorded.
The free-living activity of both groups was monitored using an activPAL TM (PAL Technologies Ltd. Glasgow, UK) activity monitor for 7 consecutive days. The monitor is a small, lightweight, thigh-worn self-contained device. This monitor has been validated for classifying upright, sedentary and standing events as well as stepping in a range of populations [10] [11] [12] [13] [14] .
The monitor was attached to the anterior part of the right thigh using either a waterproof dressing (IC participants: Opsite Flexifix TM ) or a hydrogel pad (controls: PALStickies TM , PAL Technologies Ltd. Glasgow, UK). Control participants had the option of removing the monitor whilst taking a shower/bathing, but otherwise wore the monitor continuously for 24h/d.
The data from the activPAL was first analysed using proprietary software to obtain a timestamped event history of posture (sit/stand), strides taken and associated stepping time.
The activPAL outputs the start time and duration (to the nearest 0.1s) of each stride. This output was used to determine stepping time. The outcome data was examined visually (stepping and posture) to identify any non-compliance (e.g. very few steps in a day, very few sit to stand postural transitions or extended periods of apparent sitting time which were highly uncharacteristic of the participants overall profile). Only complete 24h days were used in the analysis.
The whole period was then broken down into one-minute epochs and the time spent stepping during each minute and the associated steps (strides x 2) determined using custom software (Matlab, Mathworks Ltd.).
Outcomes
All outcomes were analysed both in terms of true cadence 1 (total number of steps divided by the stepping time) and step accumulation (total number of steps taken per minute) (the method used by Gardner et al 9 ) . Figure 1 provides an illustration of the difference between true cadence and step accumulation within one minute epochs. Within the first minute 25+20+15=60steps were taken, giving a step accumulation of 60 steps. However, the time taken to complete these steps was 15+8+7=30s. Therefore, the true cadence was 60/0.5=120steps/min. In the second minute epoch the entire period was spent stepping and 60 steps were taken. Therefore, the true cadence was 60steps/min with a step accumulation of 60steps/min. This illustrates the differences between the two outcomes for minutes with discontinuous stepping.
The overall stepping activity was described by the total number of steps/day, the number of minutes which had stepping in and the mean step accumulation in these minutes. The mean true cadence of all minute epochs with steps in was also calculated. To allow comparison with the analysis of Gardner et al 9 the minutes with <30, >=30&<60, and >=60 steps were identified. Both the true cadence and the step accumulation of these minutes were calculated. A large proportion of minutes with stepping in had true cadence >=60steps/min. Therefore, to further analyse the true cadence outcomes the upper range was subdivided: >=60&<90, >=90&<120, >=120steps/min.
Following the methods of Gardner et al 9 minutes were selected that represented the 'burst activity', characterised as the one-minute and five-minute blocks which had the maximum number of steps accumulated. 'Endurance' was characterised by finding the blocks of 20, 30 and 60 minutes which contained the maximum total number of steps. The 'Peak Activity Index' was calculated within the 30 single minute epochs with the highest step accumulation. True cadence and step accumulation were calculated for these outcomes.
Statistical analysis
Outcome distributions were examined for normality (Shapiro-Wilk). Mann Whitney U or unpaired t-tests were applied as appropriate to examine differences between outcomes for IC and control groups. A significance level of P<0.05 was used. Data are reported as either mean±standard deviation or median (25 th quartile, 75 th quartile). For multiple tests (e.g. Page 9 of 22 across several ranges of cadence) a Bonferroni correction was applied. All analysis was performed using SPSS (v19, IBM Corp.).
RESULTS
Between those with IC and controls there were no significant differences in age, gender, height, weight or BMI (all P>0.05) ( Table 1 ). All participants wore the monitor for 7 full days except 2 controls who wore the monitor for 5 days only. More of the controls (37%) were in employment that those with IC (20%). The mean duration of IC was 4.1±4.9y with participants having a mean Ankle Brachial Pressure Index (ABPi) of 0.83±0.28.
The mean number of steps per day for those with IC was significantly lower at 6531±2712 than controls 8692±2945 (P=0.003). However, this stepping activity was taken in approximately the same number of one-minute epochs (IC 301±100 and controls 300±70) (P=0.894). Thus those with IC and the controls had approximately the same number of one minute periods with stepping activity.
True cadence and step accumulation outcomes within stepping rate bands were radically different, demonstrating opposite trends, for both those with IC and controls (Figure 2A ).
True cadence demonstrated an increasing number of minutes and step accumulation a decreasing number of minutes at higher stepping rates:
For both groups the majority of one-minute epochs with stepping had a true cadence greater than 60 steps/min (IC 190(147,240)mins/d, controls 203(165,232)mins/d) (P=0.679) ( Figure 2A ). There was, however, also a large number of minutes with true cadence >=30&<60 steps/min for both those with IC (95(59,127)mins/d) and the controls (87(64,105)mins/d) (P=0.751). There were very few one-minute epochs with stepping where the true cadence was <30 steps/min (IC 14 (8, 19 )mins/d, controls 12 (10, 15) Outcomes of the number of steps classified as being within each stepping rate range ( Figure   2B ) were again quite different when characterised by true cadence and step accumulation.
Low (<30steps/min) true cadence stepping was very limited in comparison to that determined by step accumulation, whereas high (>=60 steps/min) stepping rate steps determined by true cadence were much higher than determined by step accumulation:
For the minute-epochs taken at a high true cadence (>60steps/min) the IC group took significantly fewer steps (5,258(3,843, 6,761)steps/d) than the control group (7624(5353, 9050)steps/d) (P=0.003). There were no differences between the numbers of steps taken in the low or medium ranges of true cadence ( Figure 2B ). For step accumulation those with IC took significantly fewer steps in the high (>60 steps/min) step accumulation range (1700(1100, 3082)steps/d) than controls (4255(1948, 5949)steps/d) (P<0.001).
The differences between true cadence and step accumulation for steps per day were not the same between the groups: Similar true cadence distributions ( Figure 2B Figures 3A and 3B respectively) . However, only the 'Maximum 1-min' outcomes were of similar magnitude with all other true cadence outcomes higher than the step accumulation outcomes:
All measures of 'burst', 'endurance' and 'peak activity index' were significantly different between the IC and control groups with the IC group having lower true cadence than the control group ( Figure 3A) . Similarly the outcomes based on step accumulation were also all significantly different with the IC group having a lower number of steps per minute-epoch than the controls ( Figure 3B ). Whilst for all the 'burst', 'endurance' and 'peak activity index' outcomes the median true cadence measures were all above 80 steps/minute, the steps accumulated per minute were as low as 27 for the maximum 60 min endurance category.
Of all the minutes containing stepping the median true cadence of walking was different between the IC group (69(66,72)steps/min) and the control group (72(68,76)steps/min) (P=0.026). This difference was, however, small compared to the average values exhibited.
This small difference was associated with a large difference in the number of steps accumulated per minute (IC 22(19,24)steps/min compared to controls 30(23,34)steps/min) (P<0.001). The differences between outcomes when presented by true cadence as compared to step accumulation appeared to be the same for both those with IC and the controls: All the true cadence and step accumulation 'burst' and 'endurance' outcomes were lower for the IC group.
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When the upper range of true cadence (>60steps/min) was subdivided further it was observed that there was a trend (not significant) for the IC group to have fewer minutes with a true cadence above 90 steps per minute compared to the control group ( Figure 4A ). This was associated, however, with a significant difference in the number of steps taken in the upper true cadence ranges ( Table 2) : The IC group took far fewer steps on average at higher true cadences (>=90&<120, and >=120steps/min) than the controls ( Figure 4B ).
DISCUSSION
Stepping rate has been described ambiguously in the literature 1 
. The terms 'true cadence'
and 'step accumulation' have been used here in order to illustrate differences in outcomes that result when using different definitions of stepping rate. The clinical population of those with intermittent claudication was selected as it was hypothesised that this population would have altered patterns of stepping activity due to pain when walking. It has already been reported by Gardner et al 9 that this population appear to use different distributions of stepping than an age matched group without IC. However, Gardner et al's use of 'step accumulation' means that it is not possible to know the actual stepping rate used during periods of stepping. This information can only come from true cadence: The rate of stepping when actually taking steps.
The results of the current study confirm that those with IC take fewer steps on average per day than those without (IC 6531±2712, controls 8692±2945 steps/day). This difference of over 2000 steps per day between the IC and control groups is very similar to that reported by Gardner et al 9 (6300 to 8400steps/d). The number of minutes within the day that contained walking was also similar for controls between this study (300±70mins/d) and
Gardner et al 9 (312±96mins/d). Those with IC in the current study, however, distributed their walking across a larger number of minutes than previously reported (301±100mins/d current study, compared to 264±109mins/d 9 ). This was associated with a similar average step accumulation in this study (IC 22(19, 24 )) compared to that reported by Gardner et al 9 (IC 23.6±5.8). The higher number of steps taken per day in the current study may have been due to lower average body weight and a higher proportion of male participants in the current study (60%) compared to Gardner et al's population (IC 46%, controls 55%). Also the ABPi of the IC participants in the current study (0.83 ± 0.28) was higher than that reported by Gardner et al (0.71±0.21) indicating that they were more mildly affected. The population recruited here were at the lower end of the symptom scale being relatively mildly affected 15 . It might be expected that those with a more advanced disease state might demonstrate greater impairment in walking performance. Whilst the control population self-reported as asymptomatic their ABPi was not assessed nor were further medical examinations performed. It is possible that unrecorded co-morbid conditions and cardiovascular risk factors may have influenced the results. Figure 2A demonstrates conclusively that true cadence and step accumulation for this clinical population are not equivalent, with results based on the two measures giving completely different trends for stepping rate. This emphasises the importance of using clear terminology to describe stepping rate. These differences confirm that the populations studied tended to accumulate most of their walking in periods of less than one minute 1 .
The number of steps taken within the minutes identified by true cadence and step accumulation is again radically different ( Figure 2B ), but with similar trends for a lower number of high stepping rate steps for those with IC compared to controls in the >60steps/min range. There was a difference in pattern of distribution of steps taken with stepping rate between the IC group and the controls for step accumulation in comparison to true cadence ( Figure 2B ).
Step accumulation gives the impression that the IC group have predominantly low stepping rate steps and the controls have predominantly high stepping rate steps. This difference is not present when examined by true cadence. This highlights that there is not the same relationship between step accumulation and true cadence for Page 16 of 22 these populations. This difference arises due to the particular distribution of amount of time spent stepping per minute within the two groups.
The 'burst', 'endurance' and 'peak activity index' outcomes ( Figure 3 ) advocated by Gardner et al 1 provide quantitative insight into the minutes with the largest number of steps. Our hypothesis that those with IC would demonstrate lower true cadence outcomes is proven ( Figure 3A) for these outcomes. Also this analysis demonstrates considerable differences between true cadence and step accumulation outcomes. Although these peak indicators of stepping were different between those with IC and controls the average true cadence in all minutes with stepping was different only by a small amount (3 steps/min) between groups.
This confirms that those with IC use a pattern of stepping with lower sustained high true cadence, spreading out their stepping activity more than controls, but within the same number of minute epochs.
When true cadence is used to describe stepping rate ( Figure 4 ) evidence emerges that it is only in the higher ranges of cadence, above 90steps/min, that there are differences between the groups. With a median of only 2000steps/d, those with IC took approximately 1300steps/d fewer above this threshold than controls ( Table 2) .
Analysing stepping using step accumulation, and reporting this as cadence, gives an impression that people with Intermittent Claudication walk at a low stepping rate. The results from this study show that people with Intermittent Claudication walk at much higher true cadences than have previously been reported, with mean true cadences per minute epoch being only slightly lower than that of a matched control group.
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Assessment of stepping activity against physical activity guidelines might be important for describing current activity engagement within this clinical population. The performance of moderate to vigorous physical activity (MVPA) is considered to take place above thresholds of stepping rate determined for continuous walking (e.g. a true cadence of 100steps/min) 16, 17 . The current analysis demonstrates the large differences in outcomes that might arise if stepping rate is inadvertently described using step accumulation and not true cadence.
Whilst this true cadence based analysis of minute epoch data provides some insight into the stepping rate distribution, it does not provide information on the overall stepping events that are occurring. If a stepping event (continuous stepping without a break) crossed the boundary of the one-minute epochs then it would have been split between two or more epochs. The only way to overcome this shortcoming of the current analysis would be to examine the data in an event-based manner treating the time series as continuous and composed of discrete events of stepping and non-stepping time 18 . Once a stepping event had been identified the cadence of this whole event and the distribution of cadence within this event could be used to describe stepping intensity.
CONCLUSIONS
True cadence should be used to correctly describe the rate of stepping as it is performed.
True cadence outcomes are not the same as step accumulations outcomes. Those with IC had approximately the same number of minutes per day with stepping in, but they Page 18 of 22 accumulated fewer steps within these minutes than controls. Those with IC performed 1300 fewer steps per day at high true cadence (>90 steps/min) than controls.
The measurement of true cadence under free-living conditions in the population of people with IC provides insight into the effect of their condition on stepping performance..
Stepping rate should be described unambiguously. Analysis of stepping using true cadence and step accumulation are not equivalent.
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Figure legends

Figure 1
Calculation of true cadence based on the number of steps taken and the time spent stepping.
Two one minute epochs are illustrated. Time periods where no steps are taken are indicated by dark shading. Time periods where stepping occurred are indicated by light shading, with the number of steps taken and the time to take these steps indicated. 
